235 related articles for article (PubMed ID: 33757676)
41. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome.
Barrou Z; Guiban D; Maroufi A; Fournier C; Dugué MA; Luton JP; Thomopoulos P
Eur J Endocrinol; 1996 Jan; 134(1):93-6. PubMed ID: 8590965
[TBL] [Abstract][Full Text] [Related]
42. Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing's syndrome.
Bäcklund N; Brattsand G; Israelsson M; Ragnarsson O; Burman P; Edén Engström B; Høybye C; Berinder K; Wahlberg J; Olsson T; Dahlqvist P
Eur J Endocrinol; 2020 Jun; 182(6):569-582. PubMed ID: 32213657
[TBL] [Abstract][Full Text] [Related]
43. Development and validation of a 0.5 mg dexamethasone suppression test as an initial screening test for the diagnosis of ACTH-dependent Cushing's syndrome.
Oki Y; Hashimoto K; Hirata Y; Iwasaki Y; Nigawara T; Doi M; Sakihara S; Kageyama K; Suda T
Endocr J; 2009; 56(7):897-904. PubMed ID: 19706991
[TBL] [Abstract][Full Text] [Related]
44. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the diagnostic criteria for Cushing's disease in Japan.
Kageyama K; Oki Y; Sakihara S; Nigawara T; Terui K; Suda T
Endocr J; 2013; 60(2):127-35. PubMed ID: 23171704
[TBL] [Abstract][Full Text] [Related]
46. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
al-Saadi N; Diederich S; Oelkers W
Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
[TBL] [Abstract][Full Text] [Related]
47. Screening and diagnosis of Cushing's syndrome.
Castro Md; Moreira AC
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1191-8. PubMed ID: 18209856
[TBL] [Abstract][Full Text] [Related]
48. Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay.
Deutschbein T; Broecker-Preuss M; Flitsch J; Jaeger A; Althoff R; Walz MK; Mann K; Petersenn S
Eur J Endocrinol; 2012 Apr; 166(4):613-8. PubMed ID: 22214924
[TBL] [Abstract][Full Text] [Related]
49. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency.
Raff H
J Clin Endocrinol Metab; 2009 Oct; 94(10):3647-55. PubMed ID: 19602555
[TBL] [Abstract][Full Text] [Related]
50. Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing's disease.
Trementino L; Cardinaletti M; Concettoni C; Marcelli G; Polenta B; Spinello M; Boscaro M; Arnaldi G
Pituitary; 2015 Feb; 18(1):60-7. PubMed ID: 24482099
[TBL] [Abstract][Full Text] [Related]
51. Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism.
Baid SK; Sinaii N; Wade M; Rubino D; Nieman LK
J Clin Endocrinol Metab; 2007 Aug; 92(8):3102-7. PubMed ID: 17550962
[TBL] [Abstract][Full Text] [Related]
52. Characterization of cyclic Cushing's disease using late night salivary cortisol testing.
Jahandideh D; Swearingen B; Nachtigall LB; Klibanski A; Biller BMK; Tritos NA
Clin Endocrinol (Oxf); 2018 Sep; 89(3):336-345. PubMed ID: 29873834
[TBL] [Abstract][Full Text] [Related]
53. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic value of salivary cortisol in Cushing's syndrome (CS).
Cardoso EM; Arregger AL; Tumilasci OR; Contreras LN
Clin Endocrinol (Oxf); 2009 Apr; 70(4):516-21. PubMed ID: 18710466
[TBL] [Abstract][Full Text] [Related]
55. Pituitary-adrenal axis and peripheral cortisol metabolism in obese patients.
Ceccato F; Lizzul L; Barbot M; Scaroni C
Endocrine; 2020 Aug; 69(2):386-392. PubMed ID: 32564190
[TBL] [Abstract][Full Text] [Related]
56. Cushing's disease.
Bertagna X; Guignat L; Groussin L; Bertherat J
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):607-23. PubMed ID: 19945026
[TBL] [Abstract][Full Text] [Related]
57. Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome.
Galm BP; Qiao N; Klibanski A; Biller BMK; Tritos NA
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32133504
[TBL] [Abstract][Full Text] [Related]
58. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.
Papanicolaou DA; Mullen N; Kyrou I; Nieman LK
J Clin Endocrinol Metab; 2002 Oct; 87(10):4515-21. PubMed ID: 12364428
[TBL] [Abstract][Full Text] [Related]
59. Urinary free cortisol in the diagnosis of Cushing's syndrome: how useful?
Odeniyi IA; Fasanmade OA
Niger J Clin Pract; 2013; 16(3):269-72. PubMed ID: 23771444
[TBL] [Abstract][Full Text] [Related]
60. Late-night salivary cortisol as a screening test for the diagnosis of Cushing's syndrome in Japan.
Doi M; Sekizawa N; Tani Y; Tsuchiya K; Kouyama R; Tateno T; Izumiyama H; Yoshimoto T; Hirata Y
Endocr J; 2008 Mar; 55(1):121-6. PubMed ID: 18202529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
